非ホジキンスリンパ腫(Non-Hodgkin’s Lymphoma):疫学予測(~2023)

調査会社GlobalData社が発行したリサーチレポート(データ管理コード:GDHCER061)
◆英語タイトル:EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2023
◆発行会社/調査会社:GlobalData
◆商品コード:GDHCER061
◆発行日:2014年5月5日
◆調査対象地域:グローバル
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD3,995 ⇒換算¥435,455見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD7,990 ⇒換算¥870,910見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD11,985 ⇒換算¥1,306,365見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[非ホジキンスリンパ腫(Non-Hodgkin’s Lymphoma):疫学予測(~2023)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

EpiCast Report: Non-Hodgkin’s Lymphoma – Epidemiology Forecast to 2023

Summary

Non-Hodgkin’s lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the body’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fight infections and other diseases. NHL is characterized into three types – B-cell, T-cell, and natural killer lymphocyte lymphomas. B-cell lymphomas are the most common form of NHL in developed countries. NHL ranks as the most commonly occurring hematologic cancer in adults. Despite the many advances in research, NHL remains largely incurable and the causes unknown.

GlobalData epidemiologists forecast an increase in the incident cases of B-cell NHL in the 6MM, from 89,455 incident cases in 2013 to 111,366 incident cases in 2023, with an annual growth rate (AGR) of 2.45%. In 2023, the US will have the highest number of incident cases of B-cell NHL, with 56,033 incident cases, followed by Germany with 17,176 incident cases, and the UK with 12,548 incident cases.

For this analysis, GlobalData epidemiologists utilized peer-reviewed journals and country-specific disease databases to construct the 10-year epidemiological forecast for the incident cases of follicular lymphoma, marginal zone lymphoma, DLBCL, and mantle cell lymphoma in the 6MM. A major strength of GlobalData’s epidemiological analysis is the use of available country-specific sources, allowing for a meaningful comparison of the epidemiological characteristics of B-cell NHL in the 6MM. In addition, this forecast provides detailed segmentation of the B-cell NHL for each country by age, sex, and B-cell NHL subtype, thereby providing a comprehensive view of B-cell NHL in the 6MM.

Scope

- The Non-Hodgkin’s Lymphoma (NHL) EpiCast Report provides an overview of the risk factors, comorbidities, and global and historical epidemiological trends for NHL in the six major markets (6MM) (US, France, Germany, Italy, Spain, and UK). It includes a 10-year epidemiological forecast of the incident cases of follicular lymphoma, marginal zone lymphoma, diffuse large B-cell lymphoma [DLBCL], and mantle cell lymphoma segmented by age (ages =30 years) and sex in these markets.
- The NHL epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global NHL market.
- Quantify patient populations in the global NHL market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for NHL therapeutics in each of the markets covered.

*** レポート目次(コンテンツ)***

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 9
3.3 Global Trends 12
3.3.1 US 12
3.3.2 5EU 13
3.4 Forecast Methodology 16
3.4.1 Sources Used 18
3.4.2 Sources Not Used 20
3.4.3 Forecast Assumptions and Methods 21
3.4.4 Age-Standardized Incidence Rates 24
3.5 Epidemiological Forecast of B-Cell NHL (2013-2023) 25
3.5.1 Follicular Lymphoma 25
3.5.2 Marginal Zone Lymphoma 30
3.5.3 DLBCL 36
3.5.4 Mantle Cell Lymphoma 42
3.6 Discussion 48
3.6.1 Epidemiological Forecast Insight 48
3.6.2 Limitations of the Analysis 48
3.6.3 Strengths of the Analysis 49
4 Appendix 50
4.1 Bibliography 50
4.2 About the Authors 54
4.2.1 Epidemiologists 54
4.2.2 Reviewers 54
4.2.3 Global Director of Epidemiology 55
4.2.4 Global Head of Healthcare 56
4.3 About GlobalData 57
4.4 About EpiCast 57
4.5 Disclaimer 58

1.1 List of Tables
Table 1: Risk Factors and Comorbidities for NHL 11
Table 2: US, Age- and Sex-Specific Incidence of B-Cell NHL during 2001-2010 13
Table 3: 6MM, Sources of B-Cell NHL Incidence Data 17
Table 4: 6MM, Incident Cases of Follicular Lymphoma, Ages ≥30 Years, Both Sexes, N, Selected Years 2013-2023 25
Table 5: 6MM, Age-Specific Incident Cases of Follicular Lymphoma, Both Sexes, N (Row %), 2013 27
Table 6: 6MM, Sex-Specific Incident Cases of Follicular Lymphoma, Ages ≥30 Years, N (Row %), 2013 28
Table 7: 6MM, Incident Cases of Marginal Zone Lymphoma, Ages ≥30 Years, Both Sexes, N, Selected Years 2013-2023 31
Table 8: 6MM, Age-Specific Incident Cases of Marginal Zone Lymphoma, Both Sexes, N (Row %), 2013 32
Table 9: 6MM, Sex-Specific Incident Cases of Marginal Zone Lymphoma, Ages ≥30 Years, N (Row %), 2013 34
Table 10: 6MM, Incident Cases of DLBCL, Ages ≥30 Years, Both Sexes, N, Selected Years 2013-2023 37
Table 11: 6MM, Age-Specific Incident Cases of DLBCL, Both Sexes, N (Row %), 2013 38
Table 12: 6MM, Sex-Specific Incident Cases of DLBCL, Ages ≥30 Years, N (Row %), 2013 40
Table 13: 6MM, Incident Cases of Mantle Cell Lymphoma, Ages ≥30 Years, Both Sexes, N, Selected Years 2013-2023 43
Table 14: 6MM, Age-Specific Incident Cases of Mantle Cell Lymphoma, Both Sexes, N (Row %), 2013 44
Table 15: 6MM, Sex-Specific Incident Cases of Mantle Cell Lymphoma, Ages ≥30 Years, N (Row %), 2013 46

1.2 List of Figures
Figure 1: 6MM, Incident Cases of Follicular Lymphoma, Ages ≥30 Years, Both Sexes, N, 2013-2023 26
Figure 2: 6MM, Age-Specific Incident Cases of Follicular Lymphoma, Both Sexes, N, 2013 27
Figure 3: 6MM, Sex-Specific Incident Cases of Follicular Lymphoma, Ages ≥30 Years, N, 2013 29
Figure 4: 6MM, Age-Standardized Incidence of Follicular Lymphoma (Cases per 100,000 Population), Ages ≥30 Years, 2013 30
Figure 5: 6MM, Incident Cases of Marginal Zone Lymphoma, Ages ≥30 Years, Both Sexes, N, 2013-2023 31
Figure 6: 6MM, Age-Specific Incident Cases of Marginal Zone Lymphoma, Both Sexes, N, 2013 33
Figure 7: 6MM, Sex-Specific Incident Cases of Marginal Zone Lymphoma, Ages ≥30 Years, N, 2013 35
Figure 8: 6MM, Age-Standardized Incidence of Marginal Zone Lymphoma (Cases per 100,000 Population), Ages ≥30 Years, 2013 36
Figure 9: 6MM, Incident Cases of DLBCL, Ages ≥30 Years, Both Sexes, N, 2013-2023 37
Figure 10: 6MM, Age-Specific Incident Cases of DLBCL, Both Sexes, N, 2013 39
Figure 11: 6MM, Sex-Specific Incident Cases of DLBCL, Ages ≥30 Years, N, 2013 41
Figure 12: 6MM, Age-Standardized Incidence of DLBCL (Cases per 100,000 Population), Ages ≥30 Years, 2013 42
Figure 13: 6MM, Incident Cases of Mantle Cell Lymphoma, Ages ≥30 Years, Both Sexes, N, 2013-2023 43
Figure 14: 6MM, Age-Specific Incident Cases of Mantle Cell Lymphoma, Both Sexes, N, 2013 45
Figure 15: 6MM, Sex-Specific Incident Cases of Mantle Cell Lymphoma, Ages ≥30 Years, N, 2013 46
Figure 16: 6MM, Age-Standardized Incidence of Mantle Cell Lymphoma (Cases per 100,000 Population), Ages ≥30 Years, 2013 47

*** レポートのキーワード ***

非ホジキンスリンパ腫

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • ガラスストッパーの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Glass Stopper Revenue, means the sales value of Glass Stopper This report studies sales (consumption) of Glass Stopper in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, …
  • 東ヨーロッパのフレーバーアルコール飲料市場(~2020)
    Summary Canadean's, "Flavored Alcoholic Beverages Market in East Europe to 2020: Market Guide" provides a snapshot of Flavored Alcoholic Beverages consumption in East Europe. The quantitative data in the report provides historic and forecast consumption data by country, providing marketers with the …
  • 足のマッサージの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)
    Foot Massager is an instrument or equipment dedicated to the human foot massage to promote blood circulation, in order to achieve health care function. Scope of the Report: This report focuses on the Foot Massage in Global market, especially in North America, Europe and Asia-Pacific, South America, …
  • アルチザン・アイスクリーム市場動向(~2017):フィリピン
    Synopsis The report presents detailed data on consumption trends in the Artisanal Ice Cream category in Philippines, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers & acquisitions (of …
  • 世界のカーボンブラック市場2016
    The Global Carbon Black Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Carbon Black industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Ca …
  • LS Power Group(代替エネルギー分野):企業M&A動向
    Summary LS Power Group (LS Power) is a power management company. The company develops, owns, operates and invests in power generation and electric transmission infrastructure throughout the US. It also constructs, manages and acquires power generation and transmission infrastructure. LS Power has po …
  • 世界の光電子デバイス市場2015
    The Global Optoelectronic Device Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Optoelectronic Device industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structur …
  • International Entrance Control, Inc. – 企業概要
    WMI's 'International Entrance Control, Inc. - Company Capsule' is a crucial resource for industry executives and anyone looking to access key information about 'International Entrance Control, Inc.'. WMI's 'International Entrance Control, Inc. - Company Capsule' report utilizes a wide range of prima …
  • Caixa Economica Montepio Geral:企業概要及びSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Caixa Economica Montepio Geral" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market …
  • 世界及び中国のPU 1-コンポーネントシステム市場2017
    The 'Global and Chinese PU 1-Component System Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global PU 1-Component System industry with a focus on the Chinese market. The report provides key statistics on the market status of the PU 1-Com …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHCER061 )"非ホジキンスリンパ腫(Non-Hodgkin’s Lymphoma):疫学予測(~2023)" (英文:EpiCast Report: Non-Hodgkin’s Lymphoma - Epidemiology Forecast to 2023)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。